by Elena Iemma | Nov 13, 2023 | Blog
This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your “thinking” about the day? Do you do it while running? I do! And lately, I’ve been thinking about AI and Human Intelligence in vaccine development—how far...
by Elena Iemma | May 24, 2023 | Blog
AI Meets Animal Health: Smarter Vaccine Design with EpiCC™ and Human Insight The future of animal health is being shaped by powerful new technologies. At EpiVax, we’re applying AI in animal vaccine design to improve T cell epitope coverage, strengthen immune...
by Elena Iemma | Jul 22, 2022 | Events
A big thank you to everyone that came out to the pre-conference Computational Vaccinology workshop at ISV! Agenda and pictures from the day below. ISV 2022 Computational Vaccinology Conference Workshop Saturday September 17, 9-4 pm ET Delta Hotels Québec 690 Boul René...
by Elena Iemma | Sep 10, 2021 | Events
EpiVax participated in the 2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021. The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community. Multiple EpiVax...
by Elena Iemma | May 17, 2021 | News
PROVIDENCE, RI, May 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation” in NPJ Vaccines. This research identifies...
